Rockefeller Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,888
| Closed | -$262K | – | 1565 |
|
|
2023
Q2 | $262K | Buy |
8,888
+164
| +2% | +$4.84K | ﹤0.01% | 1558 |
|
|
2023
Q1 | $200K | Sell |
8,724
-1,134
| -12% | -$26K | ﹤0.01% | 1816 |
|
|
2022
Q4 | $273K | Sell |
9,858
-1,976
| -17% | -$54.7K | ﹤0.01% | 1519 |
|
|
2022
Q3 | $362K | Buy |
11,834
+604
| +5% | +$18.5K | ﹤0.01% | 1391 |
|
|
2022
Q2 | $330K | Sell |
11,230
-8,422
| -43% | -$247K | ﹤0.01% | 1437 |
|
|
2022
Q1 | $631K | Buy |
19,652
+3,194
| +19% | +$103K | ﹤0.01% | 1228 |
|
|
2021
Q4 | $733K | Buy |
16,458
+1,659
| +11% | +$73.9K | ﹤0.01% | 1171 |
|
|
2021
Q3 | $745K | Buy |
14,799
+7,592
| +105% | +$382K | ﹤0.01% | 1106 |
|
|
2021
Q2 | $564K | Buy |
7,207
+2,817
| +64% | +$220K | ﹤0.01% | 1155 |
|
|
2021
Q1 | $249K | Buy |
4,390
+1,890
| +76% | +$107K | ﹤0.01% | 1265 |
|
|
2020
Q4 | $209K | Hold |
2,500
| – | – | ﹤0.01% | 1181 |
|
|
2020
Q3 | $89K | Buy |
+2,500
| New | +$89K | ﹤0.01% | 1298 |
|